Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of fluorinated active pharmaceutical ingredients (APIs). The bromomethyl group enables further functionalization through nucleophilic substitution, making it valuable for constructing complex molecules in medicinal chemistry. Its carbamate group acts as a protected amine, allowing controlled deprotection during multi-step syntheses. Commonly employed in the preparation of kinase inhibitors and other bioactive molecules where fluorine substitution enhances metabolic stability and binding affinity.